Author | Ben Leach

Articles

Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

December 05, 2012

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Sentinel Lymph Node Surgery After Chemotherapy Shows Accuracy in Nodal Staging in Breast Cancer

December 05, 2012

Sentinel lymph node surgery may provide a less-invasive alternative to axillary lymph node dissection for nodal staging in node-positive breast cancer.

FDA Approves Cabozantinib for Medullary Thyroid Cancer

November 29, 2012

The FDA has approved cabozantinib, a multi-targeted tyrosine kinase inhibitor, for the treatment of metastatic medullary thyroid cancer.

Use of Tolvaptan in Hyponatremic Patients Reduces Hospital Costs, Study Finds

April 02, 2012

Tolvaptan, a vasopression V2 receptor antagonist used to increase low levels of sodium in the blood, could be a cost effective way of managing patients who have hyponatremia.